Both in Pharmaceuticals
GT Biopharma vs CalciMedica
Over the past year GTBP returned −67.1% and CALC returned −90.6%; their daily moves had a correlation of 0.02.
GTBP −67.1% CALC −90.6%Growth of $1, one year, split-adjusted
| Metric | GTBP | CALC |
|---|---|---|
| Price | $5.13 | $1.40 |
| Market cap | $9.3M | $9.6M |
| Today | −3.57% | −4.11% |
| 1 month | −15.9% | −12.5% |
| 6 months | −46.4% | −52.2% |
| Year to date | −73.9% | −95.8% |
| 1 year | −67.3% | −90.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $5.0M | $9.4M |
| Dividend yield | — | — |
| Volatility (60d) | 958.2% | 487.5% |
| Short % of float | 24.1% | 0.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).